BTG3 and systemic sclerosis: Although we should not classify all ANA-positive acute renal failure or ILD as systemic sclerosis sine scleroderma, identifying SSc-specific autoantibodies may prove useful in understanding the pathogenetic mechanism and selecting treatment options.